TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 48 filers reported holding TALIS BIOMEDICAL CORP in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,028 | -41.8% | 10,476 | -46.0% | 0.00% | – |
Q4 2022 | $8,637 | -13.6% | 19,409 | +55.2% | 0.00% | – |
Q2 2022 | $10,000 | -33.3% | 12,508 | +15.8% | 0.00% | – |
Q1 2022 | $15,000 | -93.8% | 10,805 | -81.9% | 0.00% | – |
Q4 2021 | $240,000 | -80.9% | 59,834 | -70.2% | 0.00% | – |
Q3 2021 | $1,256,000 | – | 200,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 2,235,783 | $1,073,176 | 0.05% |
WELLS FARGO & COMPANY/MN | 174 | $84 | 0.00% |
NORTHERN TRUST CORP | 27,860 | $13,373 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 140,530 | $67,454 | 0.00% |
STATE STREET CORP | 47,436 | $22,769 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 91,463 | $43,902 | 0.00% |
DEUTSCHE BANK AG\ | 45,294 | $21,741 | 0.00% |
MORGAN STANLEY | 61,857 | $29,691 | 0.00% |
BlackRock Inc. | 76,307 | $36,628 | 0.00% |